Titlebook: Best Practices of Apheresis in Hematopoietic Cell Transplantation; Syed A. Abutalib,Anand Padmanabhan,Nina Worel Book 2020 Springer Nature

不近人情

P. Marche,A. Girard,S. Koutouzovropriate anticoagulation of the extracorporeal circuit to sustain flow rates of 50–100?mL/min. This chapter discusses these practical considerations regarding apheresis HPC collections and how one might maximize procedure efficacy and safety.

Outshine

restrain

Anticoagulation and Other Periprocedural Considerations for Apheresis,ropriate anticoagulation of the extracorporeal circuit to sustain flow rates of 50–100?mL/min. This chapter discusses these practical considerations regarding apheresis HPC collections and how one might maximize procedure efficacy and safety.

Dappled

Mabel Hokin-Neaverson,Gregory S. Parrieser focus on their implementation in the treatment of three hematological diseases, thrombotic microangiopathy, acquired coagulation inhibitors, and pure red cell aplasia after major ABO-incompatible allogenic hematopoietic stem cell transplantation.

使尷尬

創(chuàng)作

率直

Hongying Lin,Karsten Lindner,Georg W. Mayrlatory agencies, national and international registries, and accreditation bodies have facilitated the availability and safe provision of human cells, tissues, and cellular- and tissue-based products not only at local institutions but also through international exchange.

fabricate

灰姑娘

FACT-JACIE Standards: Common Citations and How Best to Avoid Them, integrate into the collection of hematopoietic progenitor cell (HPC) products to address and avoid these citations as well as to provide high-quality cells to patients will be discussed. The trends discussed in this chapter reflect inspections performed by the Foundation for Accreditation of Cellular Therapy (FACT).

Vital-Signs

Donor Evaluation for Hematopoietic Stem and Progenitor Cell Collection,latory agencies, national and international registries, and accreditation bodies have facilitated the availability and safe provision of human cells, tissues, and cellular- and tissue-based products not only at local institutions but also through international exchange.